Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for PCVX

Stock NameVaxcyte Inc
TickerPCVX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS92243G1085
LEI254900M7NMHTGASX8D95

Show aggregate PCVX holdings

News associated with PCVX

Vaxcyte, Inc. (NASDAQ:PCVX) Receives $106.25 Average Price Target from Analysts
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) has received an average rating of “Buy” from the seven analysts that are currently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The […] - 2025-09-16 02:32:42
Swiss National Bank Has $8.21 Million Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX)
Swiss National Bank reduced its holdings in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 0.8% in the 1st quarter, HoldingsChannel reports. The fund owned 217,300 shares of the company’s stock after selling 1,700 shares during the period. Swiss National Bank’s holdings in Vaxcyte were worth $8,205,000 at the end of the most recent quarter. Several […] - 2025-08-17 05:55:01
Natixis Advisors LLC Decreases Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)
Natixis Advisors LLC lowered its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 5.7% during the first quarter, Holdings Channel reports. The institutional investor owned 14,649 shares of the company’s stock after selling 888 shares during the period. Natixis Advisors LLC’s holdings in Vaxcyte were worth $553,000 at the end of the […] - 2025-08-12 04:38:46
Analysts Forecast 12% Upside For JHML
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:57:29
KLP Kapitalforvaltning AS Buys 500 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)
KLP Kapitalforvaltning AS increased its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 2.2% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 23,000 shares of the company’s stock after purchasing an additional 500 shares during the quarter. KLP Kapitalforvaltning AS’s holdings in Vaxcyte […] - 2025-07-29 06:16:55
Universal Beteiligungs und Servicegesellschaft mbH Buys 3,634 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)
Universal Beteiligungs und Servicegesellschaft mbH raised its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 3.5% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 107,317 shares of the company’s stock after buying an additional 3,634 shares during the quarter. Universal […] - 2025-07-29 05:22:57
Brokerages Set Vaxcyte, Inc. (NASDAQ:PCVX) Target Price at $136.50
Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) have been given a consensus rating of “Buy” by the ten ratings firms that are covering the firm, MarketBeat Ratings reports. Nine investment analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month […] - 2025-07-28 02:30:52
New York State Common Retirement Fund Increases Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)
New York State Common Retirement Fund increased its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 190.6% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 137,440 shares of the company’s stock after purchasing an additional 90,145 shares during the quarter. New York […] - 2025-07-22 07:09:01
Principal Financial Group Inc. Has $17.73 Million Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)
Principal Financial Group Inc. raised its holdings in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 52.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 469,561 shares of the company’s stock after acquiring an additional 160,622 shares during the period. […] - 2025-07-11 05:21:08
Calamos Advisors LLC Has $257,000 Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)
Calamos Advisors LLC decreased its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 32.0% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 6,794 shares of the company’s stock after selling 3,201 shares during the period. Calamos Advisors LLC’s holdings in Vaxcyte were worth […] - 2025-07-08 05:46:54
Vaxcyte, Inc. (NASDAQ:PCVX) Holdings Lowered by Allspring Global Investments Holdings LLC
Allspring Global Investments Holdings LLC trimmed its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 43.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 335,990 shares of the company’s stock after selling 257,533 shares during the […] - 2025-07-04 05:06:38
Analysts Set Vaxcyte, Inc. (NASDAQ:PCVX) Price Target at $136.50
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) has been given a consensus rating of “Buy” by the ten ratings firms that are covering the firm, Marketbeat.com reports. Nine research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12-month price objective among […] - 2025-07-03 02:42:45
Analyzing Vaxcyte (NASDAQ:PCVX) & Genenta Science (NASDAQ:GNTA)
Genenta Science (NASDAQ:GNTA – Get Free Report) and Vaxcyte (NASDAQ:PCVX – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, valuation, dividends, institutional ownership and analyst recommendations. Volatility & Risk Genenta Science has a beta of […] - 2025-06-13 02:32:52
The Math Shows ESML Can Go To $48
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-05 07:20:56
Vaxcyte, Inc. (NASDAQ:PCVX) Receives Average Rating of “Buy” from Brokerages
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) has earned an average recommendation of “Buy” from the ten analysts that are currently covering the stock, Marketbeat reports. Nine investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price objective among analysts […] - 2025-06-05 02:32:50
Head to Head Contrast: Vaxcyte (NASDAQ:PCVX) and Beam Therapeutics (NASDAQ:BEAM)
Vaxcyte (NASDAQ:PCVX – Get Free Report) and Beam Therapeutics (NASDAQ:BEAM – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings and dividends. Risk and Volatility Vaxcyte has a beta of 1.27, […] - 2025-05-30 02:28:51
Millennium Management LLC Sells 21,857 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)
Millennium Management LLC lessened its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 7.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 276,578 shares of the company’s stock after selling 21,857 shares during the quarter. Millennium Management LLC owned approximately […] - 2025-05-21 05:46:50
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Bought by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP increased its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 115.3% during the fourth quarter, HoldingsChannel.com reports. The fund owned 293,706 shares of the company’s stock after buying an additional 157,277 shares during the period. Dimensional Fund Advisors LP’s holdings in Vaxcyte were worth $24,043,000 at the end of the […] - 2025-05-07 05:22:50
Mariner LLC Has $487,000 Position in Vaxcyte, Inc. (NASDAQ:PCVX)
Mariner LLC boosted its position in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 27.7% in the 4th quarter, HoldingsChannel.com reports. The firm owned 5,947 shares of the company’s stock after buying an additional 1,290 shares during the period. Mariner LLC’s holdings in Vaxcyte were worth $487,000 as of its most recent filing with the Securities […] - 2025-05-02 05:10:52
Renaissance Technologies LLC Purchases Shares of 54,077 Vaxcyte, Inc. (NASDAQ:PCVX)
Renaissance Technologies LLC acquired a new position in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 54,077 shares of the company’s stock, valued at approximately $4,427,000. A number of other hedge funds and other institutional investors […] - 2025-04-22 05:03:18
ILCB's Holdings Imply 27% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-04 08:46:47
Norges Bank Acquires Shares of 1,100,286 Vaxcyte, Inc. (NASDAQ:PCVX)
Norges Bank bought a new position in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 1,100,286 shares of the company’s stock, valued at approximately $90,069,000. Norges Bank owned about 0.88% of Vaxcyte at the end of the most […] - 2025-04-03 05:36:54
Bank of America Lowers Vaxcyte (NASDAQ:PCVX) Price Target to $137.00
Vaxcyte (NASDAQ:PCVX – Get Free Report) had its price target reduced by research analysts at Bank of America from $157.00 to $137.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Bank of America‘s price objective would suggest a potential upside of 306.65% from the […] - 2025-04-03 04:24:52
Needham & Company LLC Has Lowered Expectations for Vaxcyte (NASDAQ:PCVX) Stock Price
Vaxcyte (NASDAQ:PCVX – Get Free Report) had its target price lowered by investment analysts at Needham & Company LLC from $140.00 to $90.00 in a report released on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Needham & Company LLC’s price target would suggest a potential upside of 167.14% from the […] - 2025-04-03 04:24:52
Monday's ETF Movers: FBT, XBI
In trading on Monday, the First Trust NYSE Arca Biotechnology Index Fund ETF is outperforming other ETFs, up about 1.9% on the day. Components of that ETF showing particular strength include shares of Corcept Therapeutics, up about 83.2% and shares of Amgen, up about 2% on the - 2025-03-31 13:11:30
Proficio Capital Partners LLC Invests $2.92 Million in Vaxcyte, Inc. (NASDAQ:PCVX)
Proficio Capital Partners LLC purchased a new stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) during the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 35,609 shares of the company’s stock, valued at approximately $2,915,000. Several other large investors have also recently added to or reduced their stakes in the company. Whipplewood Advisors […] - 2025-03-19 05:44:45
PNC Financial Services Group Inc. Boosts Stake in Vaxcyte, Inc. (NASDAQ:PCVX)
PNC Financial Services Group Inc. increased its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 18.2% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 9,076 shares of the company’s stock after acquiring an additional 1,397 shares during the period. PNC Financial Services Group Inc.’s holdings […] - 2025-03-18 05:38:57
Victory Capital Management Inc. Has $24.85 Million Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX)
Victory Capital Management Inc. lifted its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 19.0% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 303,556 shares of the company’s stock after purchasing an additional 48,516 shares during the quarter. Victory Capital Management Inc. owned […] - 2025-03-11 06:16:48
Brokerages Set Vaxcyte, Inc. (NASDAQ:PCVX) PT at $127.71
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) has been given a consensus recommendation of “Buy” by the nine ratings firms that are covering the company, MarketBeat Ratings reports. Nine analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have issued ratings on the stock in the last […] - 2025-02-28 04:06:48
After-Hours Earnings Report for February 25, 2025 : INTU, WDAY, ALC, CPNG, AXON, EXR, KEYS, FSLR, CART, CAVA, PCVX, PR
The following companies are expected to report earnings after hours on 02/25/2025. Visit our Earnings Calendar for a full list of expected earnings releases.Intuit Inc. (INTU)is reporting for the quarter ending January 31, 2025. The computer software company's consensus earnings - 2025-02-25 17:00:00

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc PCVX holdings

DateNumber of PCVX Shares HeldBase Market Value of PCVX SharesLocal Market Value of PCVX SharesChange in PCVX Shares HeldChange in PCVX Base ValueCurrent Price per PCVX Share HeldPrevious Price per PCVX Share Held
2025-11-12 (Wednesday)61,643PCVX holding decreased by -202USD 2,841,742PCVX holding increased by 17899USD 2,841,742-202USD 17,899 USD 46.1 USD 45.66
2025-11-11 (Tuesday)61,845USD 2,823,843PCVX holding increased by 169456USD 2,823,8430USD 169,456 USD 45.66 USD 42.92
2025-11-10 (Monday)61,845USD 2,654,387PCVX holding increased by 78543USD 2,654,3870USD 78,543 USD 42.92 USD 41.65
2025-11-07 (Friday)61,845USD 2,575,844PCVX holding decreased by -3711USD 2,575,8440USD -3,711 USD 41.65 USD 41.71
2025-11-06 (Thursday)61,845PCVX holding decreased by -202USD 2,579,555PCVX holding increased by 77820USD 2,579,555-202USD 77,820 USD 41.71 USD 40.32
2025-11-05 (Wednesday)62,047PCVX holding decreased by -2020USD 2,501,735PCVX holding decreased by -147435USD 2,501,735-2,020USD -147,435 USD 40.32 USD 41.35
2025-11-04 (Tuesday)64,067PCVX holding decreased by -404USD 2,649,170PCVX holding decreased by -112123USD 2,649,170-404USD -112,123 USD 41.35 USD 42.83
2025-11-03 (Monday)64,471PCVX holding decreased by -404USD 2,761,293PCVX holding decreased by -176247USD 2,761,293-404USD -176,247 USD 42.83 USD 45.28
2025-10-31 (Friday)64,875USD 2,937,540PCVX holding increased by 34384USD 2,937,5400USD 34,384 USD 45.28 USD 44.75
2025-10-30 (Thursday)64,875USD 2,903,156PCVX holding increased by 79796USD 2,903,1560USD 79,796 USD 44.75 USD 43.52
2025-10-29 (Wednesday)64,875USD 2,823,360PCVX holding decreased by -68119USD 2,823,3600USD -68,119 USD 43.52 USD 44.57
2025-10-28 (Tuesday)64,875PCVX holding increased by 606USD 2,891,479PCVX holding increased by 27010USD 2,891,479606USD 27,010 USD 44.57 USD 44.57
2025-10-27 (Monday)64,269USD 2,864,469PCVX holding increased by 150389USD 2,864,4690USD 150,389 USD 44.57 USD 42.23
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of PCVX by Blackrock for IE00B3VWM098

Show aggregate share trades of PCVX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-12SELL-202 46.100* 57.00 Profit of 11,514 on sale
2025-11-06SELL-20242.03040.160 40.347USD -8,150 57.29 Profit of 3,423 on sale
2025-11-05SELL-2,02041.80039.870 40.063USD -80,927 57.38 Profit of 34,982 on sale
2025-11-04SELL-40443.21640.790 41.033USD -16,577 57.46 Profit of 6,639 on sale
2025-11-03SELL-40445.90042.565 42.898USD -17,331 57.54 Profit of 5,916 on sale
2025-10-28BUY60644.57045.500 45.407USD 27,517 57.82
2025-10-24SELL-20242.23042.585 42.549USD -8,595 57.98 Profit of 3,117 on sale
2025-10-15BUY1,21243.94045.130 45.011USD 54,553 58.58
2025-10-02BUY20240.13040.240 40.229USD 8,126 58.78
2025-09-30BUY40436.02036.575 36.520USD 14,754 59.03
2025-08-21SELL-25731.91032.165 32.140USD -8,260 59.81 Profit of 7,112 on sale
2025-07-31BUY76833.95034.705 34.630USD 26,595 60.14
2025-07-28SELL-25635.87036.742 36.655USD -9,384 60.60 Profit of 6,130 on sale
2025-06-30SELL-51232.51033.620 33.509USD -17,157 63.60 Profit of 15,406 on sale
2025-06-25SELL-25633.09034.120 34.017USD -8,708 64.24 Profit of 7,738 on sale
2025-06-20SELL-51432.87033.710 33.626USD -17,284 64.91 Profit of 16,078 on sale
2025-05-30BUY9,78032.49033.150 33.084USD 323,562 68.52
2025-05-23BUY22332.54033.795 33.669USD 7,508 70.04
2025-05-19SELL-22332.03032.805 32.728USD -7,298 71.27 Profit of 8,596 on sale
2025-05-15SELL-66930.90031.150 31.125USD -20,823 71.97 Profit of 27,329 on sale
2025-05-12SELL-22331.59032.990 32.850USD -7,326 73.10 Profit of 8,976 on sale
2025-05-09SELL-22331.16033.470 33.239USD -7,412 73.48 Profit of 8,974 on sale
2025-04-30SELL-22335.84036.250 36.209USD -8,075 76.24 Profit of 8,926 on sale
2025-04-24SELL-44634.51034.520 34.519USD -15,395 77.95 Profit of 19,372 on sale
2025-04-17SELL-22330.65030.680 30.677USD -6,841 80.44 Profit of 11,097 on sale
2025-04-15SELL-66930.23032.720 32.471USD -21,723 81.54 Profit of 32,829 on sale
2025-04-14SELL-66932.04032.500 32.454USD -21,712 82.09 Profit of 33,204 on sale
2025-04-09SELL-89230.80032.450 32.285USD -28,798 83.86 Profit of 46,006 on sale
2025-04-07SELL-1,56132.51034.110 33.950USD -52,996 85.08 Profit of 79,818 on sale
2025-04-04SELL-2,23031.60033.250 33.085USD -73,780 85.71 Profit of 117,358 on sale
2025-04-01BUY22332.23037.920 37.351USD 8,329 86.98
2025-03-19SELL-44676.14076.380 76.356USD -34,055 89.22 Profit of 5,736 on sale
2025-03-17BUY1,33075.23075.920 75.851USD 100,882 89.61
2025-03-14SELL-1,31474.37075.040 74.973USD -98,515 89.83 Profit of 19,519 on sale
2025-03-13SELL-44073.02076.510 76.161USD -33,511 90.07 Profit of 6,119 on sale
2025-03-12SELL-7,48073.24075.000 74.824USD -559,684 90.31 Profit of 115,846 on sale
2025-03-07SELL-44071.18075.080 74.690USD -32,864 91.24 Profit of 7,280 on sale
2025-03-06SELL-66074.81076.380 76.223USD -50,307 91.49 Profit of 10,075 on sale
2025-03-03SELL-22072.10074.480 74.242USD -16,333 92.43 Profit of 4,001 on sale
2025-02-28SELL-1,32073.02075.255 75.031USD -99,042 92.75 Profit of 23,383 on sale
2025-02-26SELL-22078.65083.330 82.862USD -18,230 93.30 Profit of 2,296 on sale
2025-02-25SELL-66079.35082.770 82.428USD -54,402 93.54 Profit of 7,334 on sale
2025-02-18BUY1,10082.47085.220 84.945USD 93,440 94.63
2025-02-13BUY22083.84086.445 86.184USD 18,961 95.27
2025-02-12BUY22085.42086.680 86.554USD 19,042 95.48
2025-02-11BUY66085.13085.503 85.466USD 56,407 95.69
2025-02-06BUY1,98089.01591.020 90.819USD 179,823 96.24
2025-01-27BUY22090.91093.000 92.791USD 20,414 97.79
2024-12-30BUY1,10081.99082.210 82.188USD 90,407 99.19
2024-12-06BUY88093.31093.980 93.913USD 82,643 99.91
2024-12-05BUY22090.04093.230 92.911USD 20,440 100.26
2024-12-04BUY1,10093.04093.490 93.445USD 102,789 100.51
2024-11-29BUY1,10094.34094.375 94.371USD 103,809 101.52
2024-11-27BUY87693.98094.050 94.043USD 82,382 102.18
2024-11-26BUY21991.45092.610 92.494USD 20,256 102.67
2024-11-25BUY13,32991.70092.145 92.100USD 1,227,608 103.19
2024-11-21BUY89588.39092.870 92.422USD 82,718 104.74
2024-11-20BUY53785.96088.065 87.855USD 47,178 105.78
2024-11-18BUY2,14886.49087.320 87.237USD 187,385 108.16
2024-11-12BUY1,43299.380103.300 102.908USD 147,364 108.74
2024-11-08BUY895106.670107.305 107.242USD 95,981 108.89
2024-11-07BUY2,670102.700106.980 106.552USD 284,494 109.36
2024-11-06BUY356104.070116.000 114.807USD 40,871 109.81
2024-10-31BUY178106.350108.720 108.483USD 19,310 111.25
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of PCVX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19204,24681702,29129.1%
2025-09-18247,3181471,182,12220.9%
2025-09-17478,61801,628,29629.4%
2025-09-16258,6320784,30133.0%
2025-09-15193,594318494,38039.2%
2025-09-12262,3070527,65949.7%
2025-09-11181,6190473,83938.3%
2025-09-10278,9386810,10834.4%
2025-09-09197,2761,000484,76440.7%
2025-09-08356,154300666,46453.4%
2025-09-05251,6680581,15043.3%
2025-09-04288,8274,175579,05449.9%
2025-09-03282,3050622,62645.3%
2025-09-02220,3200734,35730.0%
2025-08-29107,9760267,83540.3%
2025-08-28260,5540594,66643.8%
2025-08-27179,7460724,10324.8%
2025-08-26114,1000664,62817.2%
2025-08-25196,8460900,65721.9%
2025-08-22120,8500342,73535.3%
2025-08-21153,745120483,24331.8%
2025-08-20118,3800353,36033.5%
2025-08-19113,5500325,27734.9%
2025-08-18156,8690446,08335.2%
2025-08-15144,4531,997521,83527.7%
2025-08-14214,7060564,08838.1%
2025-08-13219,025671,278,22117.1%
2025-08-12247,22889705,27935.1%
2025-08-11233,662136622,09637.6%
2025-08-08117,17110,8411,145,85810.2%
2025-08-07318,95520,8871,174,51827.2%
2025-08-06125,4830261,57148.0%
2025-08-05114,223106238,07548.0%
2025-08-04100,2050238,74842.0%
2025-08-01140,1902,064321,07743.7%
2025-07-31128,7450378,86734.0%
2025-07-30138,6300351,93439.4%
2025-07-29181,456445398,37845.5%
2025-07-28128,91069541,00623.8%
2025-07-25143,535100357,21940.2%
2025-07-24112,578199342,45032.9%
2025-07-23116,822100187,70062.2%
2025-07-22162,681225214,66775.8%
2025-07-21255,787100321,41979.6%
2025-07-18262,89466397,87866.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.